![These highlights do not include all the information needed to use PLEGRIDY® safely and effectively. See full prescribing information for PLEGRIDY. PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous or intramuscular useInitial U.S. Approval: These highlights do not include all the information needed to use PLEGRIDY® safely and effectively. See full prescribing information for PLEGRIDY. PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous or intramuscular useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=ple00-0022-82.jpg&id=672679)
These highlights do not include all the information needed to use PLEGRIDY® safely and effectively. See full prescribing information for PLEGRIDY. PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous or intramuscular useInitial U.S. Approval:
![Plegridy (Peginterferon Beta-1a) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today Plegridy (Peginterferon Beta-1a) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today](https://multiplesclerosisnewstoday.com/wp-content/uploads/2022/05/Plegridy-4.png)
Plegridy (Peginterferon Beta-1a) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today
PLEGRIDY Instructions for Use 3/(*5,'< 6XEFXWDQHRXV 3HQ $GPLQLVWUDWLRQ 3DFN P/(*5,'< 6XEFXWDQHRXV 3HQ 6WDUWHU 3DFN 3/(*5,
![Plegridy (peginterferon beta-1a) approved in the USA for treatment of multiple sclerosis - NeuroNews International Plegridy (peginterferon beta-1a) approved in the USA for treatment of multiple sclerosis - NeuroNews International](https://neuronewsinternational.com/wp-content/uploads/sites/3/2016/02/plegridy_main.jpg)
Plegridy (peginterferon beta-1a) approved in the USA for treatment of multiple sclerosis - NeuroNews International
PLEGRIDY Instructions for Use 3/(*5,'< 6XEFXWDQHRXV 3HQ $GPLQLVWUDWLRQ 3DFN P/(*5,'< 6XEFXWDQHRXV 3HQ 6WDUWHU 3DFN 3/(*5,
![Biogen Idec's PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis | Biogen Biogen Idec's PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis | Biogen](http://mms.businesswire.com/media/20140815005610/en/427585/5/PLEG_125mcg_PEN_Cap_Off_SMP_HR.jpg)